Drugs / HTK Custodiol
HTK Custodiol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01614951 | Jul 2012 → Nov 2013 | chronic obstructive pulmonary disease | Rigshospitalet, Denmark | Completed | Mixed |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HTK Custodiol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01614951 ↗ |
| Known as | Custodiol HTK | “Custodiol™ HTK (histidine-tryptophan-ketoglutarate) solution” PMID 25539792 ↗ Dec 2014 |
| Known as | histidine-tryptophan-ketoglutarate | “Custodiol™ HTK (histidine-tryptophan-ketoglutarate) solution” PMID 25539792 ↗ Dec 2014 |